Page Loader Image
  • About Us
  • Knowledge Hub
  • Resources
  • Events
  • In the media
  • Contact
Public Pharma For Europe
Public Pharma For Europe
Public Pharma For Europe
  • About Us
  • Knowledge Hub
  • Resources
  • Events
  • In the media
  • Contact
Public Pharma For Europe
  • About Us
  • Knowledge Hub
  • Resources
  • Events
  • In the media
  • Contact

Access materials related to Public Pharma

Against the normalization of limited access to CAR-T cell therapies

Opinion article
Read More

If Not Now, Then When? Reimagining Global Health Equity

Opinion article
Read More

Fearing Trump cuts, California Democrat proposes creating state’s own NIH

Read More

Leven van Erik (55) uit Oosterhesselen gered door experimenteel medicijn UMCG. ‘Kritiek farmalobby tenenkrommend’

News article
Read More

Para confrontar a Big Pharma, Farmacêuticas Públicas

News article
Read More

Shortage of antiseizure medication in Germany: How big is the problem?

Research paper
Read More

What a $2 Million Per Dose Gene Therapy Reveals About Drug Pricing

News article
Read More

Prix des médicaments : “Le modèle d’affaire de l’industrie pharmaceutique sert à maximiser ses profits”

Interview
Read More

Public Pharma: What It Is and Why It’s Important?

Policy brief
Read More

Technology transfer, intellectual property, and the fight for the soul of WHO

Research paper
Read More

Pagination

1 2 3 4 Next

Keep In Touch

Twitter Instagram Mastodon Linkedin

MENU

  • About us
  • Events
  • Knowledge Hub
  • Resources
  • Contact